Exclusive US distributor Phase Scientific will now roll out the rapid test via an established commercial footprint and other distribution agreements.

Clinical labs are exploring new business opportunities as consumers take more control of their healthcare and bypass their ...

The approval marks the eighth FDA-approved CDx indication for the company's PD-L1 IHC 22C3 pharmDx, Code SK006, test for use with Keytruda.

With the license, MeMed can offer its BV test, which is intended to distinguish between bacterial and viral infections, in Canada.

NEW YORK – Liquid biopsy firm Virchow Medical announced on Wednesday that it has completed a $4 million seed financing led by Cerberus Ventures. Virchow will use the funding to complete development of ...

An initial $1.35 million has been deployed to the University of California, San Francisco, to initiate the program, with additional funding announcements forthcoming.

The test detects up to 25 viral and bacterial targets, including SARS-CoV-2, influenza, Bordetella pertussis, and RSV, in one patient sample.

After years of operating in the research markets, IDT has launched IVD assays based on the core chemistry capabilities from the company's Archer portfolio.

The firms, based in the UK and in France, are collaborating to develop an ELISA assay for a novel biomarker of severe sepsis known as oxidized pentraxin 3, or ox-PTX3.

Intelligenome will contribute its testing platform to an NIH-funded program centered on cell-free DNA tuberculosis detection from respiratory and blood samples.